Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

11/15/2013 | 09:34pm US/Eastern

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664
carolyn@burzynskiclinic.com


© Business Wire 2013
React to this article
Latest news
Date Title
09:06p OI : Notice to the Market - Prior Consent of ANATEL and Call of the Shareholders’ Meeting of Oi
09:06p CHINA COSCO : Positive profit alert regarding 2015 interim results
09:06p STRATUM METALS : Response to ASX Aware Query
09:06p FRASER AND NEAVE : Dispute Relating to the Sale of F&N's 55% stake in Myanmar Brewery Limited
09:04pDJPotholes Put a Dent in New York City Budget
09:03p COMMERCIAL VEHICLE : New CEO at McClarin Plastics in Hanover area has growth strategy
09:03p HEARTLAND PAYMENT SYSTEMS : Introduces Out-of-Scope Solution for pcAmerica’s POS Merchants
09:01p AMBASSADOR HOTEL : Waikiki, an Oahu Hotel, Announces Special Offers for Summer Visitors
09:01p MINERALS COUNCIL OF AUSTRALIA : Oxfam energy study should stick to facts not ideology
09:01p METALS X : Acquisition of Grosvenor Gold Project
Latest news
Advertisement
Hot News 
MOLYCORP : Entry into a Material Definitive Agreement (form 8-K)
ACCESSO TECHNOLOGY : *numis raises accesso technology price target to 910 (730) pence - 'buy'
HELLERMANNTYTON : Surges Higher On Delphi Automotive Takeover
XCHANGING : CEO Succession
CHIME COMMUNICATIONS : Set To Be Acquired By WPP And Providence
Most Read News
06:56p CHINA BIO MED REGENERATION TECHNOLOGY : Announcements and Notices - Completion of Placing of New Shares under General Mandate
07:28p PANISH SHEA & BOYLE LLP : Announces $20.5 Million Jury Verdict Against Chaffey Joint Union High School District In The Death of Teen Killed While Crossing The Street To School Bus Stop; Court Finds School District Hid Evidence To Avoid Liability
07:46p More airlines may exit - player
06:15p COMMONWEALTH BUSINESS BANK : Reports Strong Second Quarter Earnings
06:56p Interfor Reports Q2'15 Results
Most recommended articles
09:04pDJPotholes Put a Dent in New York City Budget
08:52pDJINSURANCE AUSTRALIA : IAG Creates New Division Focused on Digital Technologies
08:51pDJRelativity Media Files for Chapter 11 Bankruptcy -- Update
08:45pDJInvestigators Seek Link to Lost Jetliner
08:45pDJCOLUMBIA SPORTSWEAR : Tops Wall Street Views